The Ordinary: The Periodic Fable
From empty promises to impossible standards and overhyped ingredients: for too long, the beauty industry has taught beauty wrong.
Bellyard Partners, LLC et al. v. Falfurrias Capital Partners, LP and Global Plasma Solutions, Inc.
24-cv-4128, N.D. Ga.
(Sept. 2024)
Products with Needlepoint Bipolar Ionization technology, including GPS-FC48-AC, GPS-FC24-AC, and others
Falsely representing that products eliminate the COVID-19 virus and produce cleaner air
Falsely representing that claims are based on independent testing when the company paid for the testing and the products do not achieve the same results in real world conditions
Pending
From empty promises to impossible standards and overhyped ingredients: for too long, the beauty industry has taught beauty wrong.
Trying to take advantage of this sale may not be as smooth as advertised.
Cecilia D’Anastasio, Bloomberg
TINA.org digs into school’s debt-free claims.
Why agency independence is in the best interests of consumers.